Medulloblastoma — Trials

Medulloblastoma — Trials · CancerIndex

Clinical trials

Registered studies

204 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 61
Recruiting: 30
Ph III recruiting: 2
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (28)

clinicaltrialsPublishedShowing 201–204 of 204 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00001502	A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors	completed	Phase 1	30	National Cancer Institute (NCI)NIH	1	Mar 4, 2008	clinicaltrials
NCT00180791	High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood	unknown	Phase 2	71	Gustave Roussy, Cancer Campus, Grand ParisOTHER	1	Sep 18, 2007	clinicaltrials